Optimal designs for dose-finding studies

Journal of the American Statistical Association

Volumn 103, Issue 483, 2008, Pages 1225-1237

  Dette, Holger ^a   Bretz, Frank ^b   Pepelyshev, Andrey ^c   Pinheiro, José ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

c optimal design; Dose response; Elfving's theorem; Minimum effective dose

Indexed keywords

EID: 54949088639     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/016214508000000427     Document Type: Article

References (43)

1. Baek, I. Y., Zhu, W., Wu, X., and Wong, W. K. (2006), "Bayesian Optimal Designs for a Quantal Dose-Response Study With Potentially Missing Observations," Journal of Biopharmaceutical Statistics, 16, 679-693.
2. Biedermann, S., Dette, H., and Pepelyshev, A. (2006a), "Some Robust Designs for Percentile Estimation in Binary Response Models," Canadian Journal of Statistics, 34, 603-622.
3. Biedermann, S., Dette, H., and Zhu, W. (2006b), "Optimal Designs for Dose-Response Models With Restricted Design Spaces," Journal of the American Statistical Association, 101, 747-759.
4. Bretz, F., Pinheiro, J. C., and Branson, M. (2005), "Combining Multiple Comparisons and Modeling Techniques in Dose-Response Studies," Biometrics, 61, 738-748.
5. Budtz-Jørgensen, E. (2007), "Estimation of the Benchmark Dose by Structural Equation Models," Biostatistics, 8, 675-688.
6. Chang, M., and Chow, S.-C. (2005), "A Hybrid Bayesian Adaptive Design for Dose-Response Trials," Journal of Biopharmaceutical Statistics, 15, 677-691.
7. Cook, R. D., and Wong, W. K. (1994), "On the Equivalence of Constrained and Compound Optimal Designs," Journal of the American Statistical Association, 89, 687-692.
8. Dette, H. (1990), "A Generalization of D- and D1-Optimal Designs in Polynomial Regression," The Annals of Statistics, 18, 1784-1805.
9. _ (1993), "A New Interpretation for E-Optimal Designs in Linear Regression Models," Metrika, 40, 37-50.
10. Elfving, G. (1952), "Optimum Allocation in Linear Regression Theory," Annals of Mathematical Statistics, 23, 255-262.
11. Fedorov, V. V., and Leonov, S. L. (2001), "Optimal Design of Dose-Response Experiments: A Model-Oriented Approach," Drug Information Journal, 35, 1373-1383.
12. Ford, I., Torsney, B., and Wu, C. F. J. (1992), "The Use of a Canonical Form in the Construction of Locally Optimal Designs for Non-Linear Problems," Journal of the Royal Statistical Society, Ser. B, 54, 569-583.
13. Han, C., and Chaloner, K. (2003), "D- and c-Optimal Designs for Exponential Regression Models Used in Pharmacokinetics and Viral Dynamics," Journal of Statistical Planning and Inference, 115, 585-601.
14. Hsu, J. C., and Berger, R. L. (1999), "Stepwise Confidence Intervals Without Multiplicity Adjustment for Dose-Response and Toxicity Studies," Journal of the American Statistical Association, 94, 468-482.
15. Huber, P. J. (1975), "Robustness and Designs," in A Survey of Statistical Design and Linear Models, ed. J. N. Srivastava, Amsterdam: North-Holland, pp. 287-303.
16. King, J., and Wong, W. K. (2004), "Optimal Designs for the Power Logistic Model," Journal of Statistical Computation and Simulation, 74, 779-791.
17. Krewski, D., Smythe, R., and Fung, K. Y. (2002), "Optimal Designs for Estimating the Effective Dose in Development Toxicity Experiments," Risk Analysis, 22, 1195-1205.
18. Lauer, S., Timmer, J., van Calker, D., Maier, D., and Honerkamp, J. (1997), "Optimal Weighted Bayesian Design Applied to Dose-Response Curve Analysis," Communications in Statistics, Part A - Theories and Methods, 26, 2879-2903.
19. Läuter, E. (1974), "Experimental Design in a Class of Models," Mathematische Operationsforschung und Statistik, 5, 379-398.
20. Meeker, W. Q. (1984), "A Comparison of Accelerated Life Test Plans for Weibull and Lognormal Distributions and Type I Censoring," Technometrics, 26, 157-171.
21. Meeker, W. Q., and Escobar, L. A. (1998), Statistical Methods for Reliability Data, New York: Wiley.
22. Morales, K. H., Ibrahim, J. G., Chen, C. J., and Ryan, L. M. (2006), "Bayesian Model Averaging With Applications to Benchmark Dose Estimation for Arsenic in Drinking Water," Journal of the American Statistical Association, 101, 9-17.
23. Nelson, W. (1990), Accelerated Testing: Statistical Models, Test Plans, and Data Analyses, New York: Wiley.
24. k ," The Annals of Statistics, 10, 511-525.
25. Pinheiro, J., Bornkamp, B., and Bretz, F. (2006), "Design and Analysis of Dose-Finding Studies Combining Multiple Comparisons and Modeling Procedures," Journal of Biopharmaceutical Statistics, 16, 639-656.
26. Pukelsheim, F. (1993), Optimal Design of Experiments, New York: Wiley.
27. Pukelsheim, F., and Rieder, S. (1992), "Efficient Rounding of Approximate Design," Biometrika, 79, 763-770.
28. Pukelsheim, F., and Rosenberger, J. L. (1993), "Experimental Designs for Model Discrimination," Journal of the American Statistical Association, 88, 642-649.
29. Ruberg, S. J. (1995), "Dose-Response Studies I: Some Design Considerations," Journal of Biopharmaceutical Statistics, 5 1-14.
30. Seber, G. A. F., and Wild, C. J. (1989), Nonlinear Regression, New York: Wiley.
31. Silvey, S. D. (1980), Optimal Design, London: Chapman & Hall.
32. Tamhane, A. C., and Logan, B. R. (2002), "Multiple Test Procedures for Identifying the Minimum Effective and Maximum Safe Doses of a Drug," Journal of the American Statistical Association, 97, 293-301.
33. Thomas, N., and Ting, N. (2008), "Minimum Effective Dose," in Encyclopedia of Clinical Trials, eds. R. D'Agostino, L. Sullivan, and J. Massaro, Hoboken, NJ: Wiley, in press.
34. Ting, N. (2006), Dose Finding in Drug Development, New York: Springer.
35. Van der Vaart, A. (1998), Asymptotic Statistics, Cambridge, U.K.: Cambridge University Press.
36. Verschwele, A., and Zwerger, P. (2006), "Evaluation of Trials on Minimum Effective Dose Related to the Needed Dose of Herbicides," Journal of Plant Diseases and Protection, 20, 675-682.
37. Wang, J. (2006), "Optimal Parametric Design With Applications to Pharmacokinetic and Pharmacodynamic Trials," Journal of Applied Statistics, 8, 837-852.
38. Wiens, D. P. (1991), "Designs for Approximately Linear Regression: Two Optimality Properties of Uniform Designs," Statistics and Probability Letters, 12, 217-221.
39. _ (1998), "Robust Designs and Weights for Approximately Specified Regression Models With Heteroscedastic Errors," Journal of the American Statistical Association, 93, 1440-1450.
40. Wu, C. F. J. (1988), "Optimal Design for Percentile Estimation of a Quantal Response Curve," in Optimal Design and Analysis of Experiments, Amsterdam: Elsevier, pp. 213-222.
41. Wu, Y., Fedorov, V. V., and Propert, K. (2005), "Optimal Design for Dose Response Using Beta Distributed Responses," Journal of Biopharmaceutical Statistics, 15, 753-751.
42. Zhu, W., and Wong, W. K. (2000), "Multiple-Objective Designs in a Dose-Response Experiment," Journal of Biopharmaceutical Statistics, 10, 1-14.
43. _ (2001), "Bayesian Optimal Designs for Estimating a Set of Symmetric Quantiles," Statistics in Medicine, 20, 123-137.